These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9661790)

  • 1. [Threshold mechanism of the control of cascade proteolysis].
    Shcherbak IG
    Bioorg Khim; 1998 May; 24(5):364-9. PubMed ID: 9661790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysis of sensitized sheep erythrocytes in human sera deficient in the second component of complement.
    Knutzen Steuer KL; Sloan LB; Oglesby TJ; Farries TC; Nickells MW; Densen P; Harley JB; Atkinson JP
    J Immunol; 1989 Oct; 143(7):2256-61. PubMed ID: 2506280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Concentration-functional interrelationships in the human alternative complement activation pathway].
    Galebskaia LV; Shcherbak IG; Bel'tiukov PP; Riumina EV; Solovtsova IL
    Biokhimiia; 1993 Nov; 58(11):1796-800. PubMed ID: 8268316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lysis of horse red blood cells mediated by antibody-independent activation of the alternative pathway of chicken complement.
    Ohta H; Yoshikawa Y; Kai C; Yamanouchi K; Okada H
    Immunology; 1984 Jul; 52(3):437-44. PubMed ID: 6430791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of alternative pathway serum complement activity in the blood of the American alligator (Alligator mississippiensis).
    Merchant ME; Roche CM; Thibodeaux D; Elsey RM
    Comp Biochem Physiol B Biochem Mol Biol; 2005 Jul; 141(3):281-8. PubMed ID: 15921941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.
    Hu VW; Shin ML
    J Immunol; 1984 Oct; 133(4):2133-7. PubMed ID: 6470486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
    Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
    J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the complement system and leukocyte recruitment by Tityus serrulatus scorpion venom.
    Bertazzi DT; de Assis-Pandochi AI; Talhaferro VL; Caleiro Seixas Azzolini AE; Pereira Crott LS; Arantes EC
    Int Immunopharmacol; 2005 Jun; 5(6):1077-84. PubMed ID: 15829423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anisakis simplex: the activity of larval products on the complement system.
    García-Hernández P; Rodero M; Cuéllar C
    Exp Parasitol; 2007 Jan; 115(1):1-8. PubMed ID: 16777096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modification of proteolytic complement cascade after treatment with exogenous heparin].
    Galebskaia LV; Solovtsova IL; Riumina EV
    Vopr Med Khim; 2001; 47(1):91-7. PubMed ID: 11386002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of complement activation and effects of C1-inhibitor on the meconium-induced inflammatory reaction in human cord blood.
    Salvesen B; Nielsen EW; Harboe M; Saugstad OD; Mollnes TE
    Mol Immunol; 2009 Feb; 46(4):688-94. PubMed ID: 18950866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Proteases in complement system (author's transl)].
    Nagasawa S
    Tanpakushitsu Kakusan Koso; 1980; 25(6):531-46. PubMed ID: 7010425
    [No Abstract]   [Full Text] [Related]  

  • 13. Complement component C2, inhibiting a latent serine protease in the classical pathway of complement activation.
    Halili MA; Ruiz-Gómez G; Le GT; Abbenante G; Fairlie DP
    Biochemistry; 2009 Sep; 48(35):8466-72. PubMed ID: 19642650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural hemolytic and bactericidal activities of sea bream Sparus aurata serum are effected by the alternative complement pathway.
    Sunyer JO; Tort L
    Vet Immunol Immunopathol; 1995 Apr; 45(3-4):333-45. PubMed ID: 7676614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Activation of the complement system and its components in healthy children aged 4 to 15 years].
    Kosenkova TV; Leonova ES; Pialikova GV
    Pediatriia; 1990; (7):105. PubMed ID: 2251040
    [No Abstract]   [Full Text] [Related]  

  • 16. Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
    Tenner AJ; Frank MM
    J Immunol; 1986 Jul; 137(2):625-30. PubMed ID: 3722818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of C3 Nephritic Factor by Hemolytic Assay.
    Chabannes M; Frémeaux-Bacchi V; Chauvet S
    Methods Mol Biol; 2021; 2227():147-158. PubMed ID: 33847940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presence and characterization of complement-like activity in the amphioxus Branchiostoma belcheri tsingtauense.
    Zhang S; Wang C; Wang Y; Wei R; Jiang G; Ju H
    Zoolog Sci; 2003 Oct; 20(10):1207-14. PubMed ID: 14569143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The complement system].
    Taran LD
    Biokhimiia; 1993 May; 58(5):780-7. PubMed ID: 8338890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of the alternative approach to complement activation using C3-dependent adhesion].
    Maianskiĭ AN; Chebotar' IV; Konyshkina TM; Ado EI; Pikuza OI
    Lab Delo; 1991; (11):41-4. PubMed ID: 1722848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.